πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 19 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9220692

Methods of reducing symptoms in subjects using single dosage forms with tapering release r

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8980304

Barrel-shaped vaginal ring

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8680084

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663681

Oral dosage forms comprising progesterone and methods of making and using the same

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8580293

Monolithic intravaginal rings comprising progesterone and methods of making and uses there

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338396

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8323679

Flexible, compressed intravaginal rings, methods of making and using the same, and apparat

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8288342

Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low do

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247393

Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8226980

Orally disintegrating solid dosage forms comprising progestin and methods of making and us

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8217024

Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8202534

Attachment of a handle to a solid oral dosage form

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8148560

Vaginal tablets comprising misoprostol and methods of making and using the same

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7910126

Flexible, compressed intravaginal rings, methods of making and using the same, and apparat

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7908729

Method for making a lollipop

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7858605

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7784616

Dispenser for progestin used for acute maintenance treatment of DUB

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7772219

Methods of hormonal treatment utilizing extended cycle contraceptive regimens

TEVA WOMEN'S HEALTH, INC. Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted